Correlation Between EDAP TMS and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both EDAP TMS and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EDAP TMS and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between EDAP TMS SA and Vivos Therapeutics, you can compare the effects of market volatilities on EDAP TMS and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EDAP TMS with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of EDAP TMS and Vivos Therapeutics.

Diversification Opportunities for EDAP TMS and Vivos Therapeutics

-0.49

Correlation Coefficient

EDAP TMS  Vivos Therapeutics

Very good diversification

The 3 months correlation between EDAP and Vivos is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding EDAP TMS SA and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and EDAP TMS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EDAP TMS SA are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of EDAP TMS i.e., EDAP TMS and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between EDAP TMS and Vivos Therapeutics

Given the investment horizon of 90 days EDAP TMS SA is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, EDAP TMS SA is 1.95 times less risky than Vivos Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  268.00  in Vivos Therapeutics on April 26, 2025 and sell it today you would earn a total of  274.00  from holding Vivos Therapeutics or generate 102.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.39%
Values	Daily Returns

EDAP TMS SA  vs.  Vivos Therapeutics

EDAP TMS SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days EDAP TMS SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vivos Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with EDAP TMS and Vivos Therapeutics

The main advantage of trading using opposite EDAP TMS and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EDAP TMS position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind EDAP TMS SA and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.